Why Symptoms Alone Aren’t Enough—The Critical Role of Breath Testing in Functional GI Diagnostics

As functional GI disorders, such as Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption, continue to challenge clinicians due to symptom overlap and diagnostic ambiguity, new research underscores an important truth: symptoms and history alone are not reliable predictors of breath test outcomes. A large-scale 2024 study conducted by our research…

Understanding Return Ratio: Why It Matters and How to Improve It

As practices across the country continue to adopt non-invasive hydrogen and methane breath testing to improve diagnostic accuracy for functional gastrointestinal conditions, one performance metric is proving especially critical to clinical and operational success: the test return ratio. The short answer Return ratio is the percentage of breath test kits sent out that come back…

How Kit Registration Drives Patient Compliance and Clinical Outcomes

In gastroenterology, missed tests often mean missed diagnoses—and missed opportunities for timely, effective care. As functional GI diagnostics continue to shift toward non-invasive, value-based solutions, such as hydrogen and methane breath testing, optimizing each step of the diagnostic process has never been more critical. One of the most powerful—and often overlooked—levers to improve test completion…

The Role of Test Timing and Sampling Intervals in Diagnostic Accuracy

Accurate diagnosis of Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption relies on multiple critical factors, including the timing of the breath test and the consistency of sampling intervals. While the substrate used, patient preparation, and sample integrity all contribute to diagnostic success, the collection schedule itself plays a pivotal role…

The Importance of Proper Patient Preparation in Hydrogen and Methane Breath Testing

Hydrogen and methane breath testing is one of the most accessible, non-invasive tools for identifying Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption disorders. However, even the most scientifically validated test can yield inaccurate results if patients don’t prepare properly. In this installment of the Breath Testing Done Right series, we…

Breath Testing in Pediatrics: Revolutionizing Diagnosis of GI Disorders with Non-Invasive Precision

Breath testing in pediatric cases represents a significant advancement in diagnosing functional gastrointestinal (GI) disorders, including Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption. These tests offer a non-invasive, patient-friendly alternative to more invasive diagnostic methods, providing a crucial tool for pediatric gastroenterologists to diagnose and manage GI disorders effectively. Benefits…

The IMO Landscape: Insights from Breath Testing Research and Clinical Practice

Breath testing for methane provides indispensable insights into the presence and severity of Intestinal Methanogen Overgrowth, highlighting its critical role in modern gastroenterology. As research advances and clinical practices evolve, breath testing remains a cornerstone in diagnosing and managing IMO, offering a more straightforward path towards optimal patient care.   Intestinal Methanogen Overgrowth (IMO), formally…

Integrated Approaches to GI Health: Combining Breath Testing with Nutritional Strategies

Linking hydrogen and methane breath testing and nutritional management offers a powerful, patient-centered approach to GI health. By combining precise diagnostic insights with tailored dietary strategies, healthcare providers can address the multifaceted nature of functional GI disorders, promoting long-term wellness and patient satisfaction. This holistic method underscores the importance of considering the entire patient picture…

Breath Testing: A Reliable Compass in Navigating SIBO Diagnosis and Post-Treatment Evaluation

In the intricate journey of Small Intestinal Bacterial Overgrowth (SIBO) diagnosis and treatment, breath testing has become a beacon of clarity and a distinguishing factor in better managing these cases. A recent study published in the Journal of Neurogastroenterology and Motility reinforces the pivotal role of breath tests in diagnosing SIBO and as a crucial…

Navigating the New ICD-10 Codes for SIBO and IMO: A Comprehensive Guide

After years of industry advocacy with the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), healthcare providers now have dedicated ICD-10 codes for intestinal microbial overgrowth and its subsets, including Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO). The following provides a comprehensive guide to the updates under…